Bunzo Nakata

Summary

Affiliation: Osaka City University
Country: Japan

Publications

  1. doi request reprint Comparison of prognosis between patients of pancreatic head cancer with and without obstructive jaundice at diagnosis
    Bunzo Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1 4 3 Asahimachi, Abeno Ku, Osaka 545 8585, Japan Electronic address
    Int J Surg 11:344-9. 2013
  2. doi request reprint Spontaneously complete regression of pseudolymphoma of the remnant pancreas after pancreaticoduodenectomy
    B Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1 4 3 Asahimachi, Abeno Ku, Osaka 545 8585, Japan
    Pancreatology 12:215-8. 2012
  3. ncbi request reprint Clinical significance of serum soluble intercellular adhesion molecule 1 in gastric cancer
    B Nakata
    First Department of Surgery, Osaka City University Medical School, Osaka, Japan
    Clin Cancer Res 6:1175-9. 2000
  4. pmc Plasma pharmacokinetics after combined therapy of gemcitabine and oral S-1 for unresectable pancreatic cancer
    Bunzo Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka 545 8585, Japan
    J Exp Clin Cancer Res 29:15. 2010
  5. doi request reprint Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer
    Bunzo Nakata
    Department of Surgical Oncology, Institute of Geriatrics and Medical Science, Osaka City University Graduate School of Medicine, Osaka, Japan
    Oncology 74:69-75. 2008
  6. ncbi request reprint Comparison of clinicopathological characteristics of curatively resected pancreatic head and body/tail ductal cancers
    B Nakata
    Department of Surgical Oncology, Institute of Geriatrics and Medical Science, Osaka City University Graduate School of Medicine, Osaka, Japan
    J Exp Clin Cancer Res 26:459-66. 2007
  7. ncbi request reprint Continuous infusion of 5-fluorouracil with versus without low-dose, consecutive administration of cisplatin in advanced colorectal cancer. A prospective randomized phase II study
    B Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
    J Exp Clin Cancer Res 26:51-60. 2007
  8. ncbi request reprint Prognostic predictive value of endoscopic ultrasound findings for invasive ductal carcinomas of pancreatic head
    Bunzo Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
    Pancreas 30:200-5. 2005
  9. ncbi request reprint Moderate neutropenia with S-1 plus low-dose cisplatin may predict a more favourable prognosis in advanced gastric cancer
    B Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
    Clin Oncol (R Coll Radiol) 18:678-83. 2006
  10. ncbi request reprint Transplatin, a cisplatin trans-isomer, may enhance the anticancer effect of 5-fluorouracil
    B Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
    J Exp Clin Cancer Res 25:195-200. 2006

Collaborators

Detail Information

Publications46

  1. doi request reprint Comparison of prognosis between patients of pancreatic head cancer with and without obstructive jaundice at diagnosis
    Bunzo Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1 4 3 Asahimachi, Abeno Ku, Osaka 545 8585, Japan Electronic address
    Int J Surg 11:344-9. 2013
    ..The aim of this study was to elicit possible differences in prognoses and clinicopathological factors in pancreatic head cancer with and without obstructive jaundice at diagnosis...
  2. doi request reprint Spontaneously complete regression of pseudolymphoma of the remnant pancreas after pancreaticoduodenectomy
    B Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1 4 3 Asahimachi, Abeno Ku, Osaka 545 8585, Japan
    Pancreatology 12:215-8. 2012
    ..Pancreatic pseudolymphoma is extremely rare...
  3. ncbi request reprint Clinical significance of serum soluble intercellular adhesion molecule 1 in gastric cancer
    B Nakata
    First Department of Surgery, Osaka City University Medical School, Osaka, Japan
    Clin Cancer Res 6:1175-9. 2000
    ..In conclusion, serum sICAM-1 cannot be used as a tumor marker for early diagnosis. However, sICAM-1 in sera may still be worthwhile to measure for monitoring hematogenous metastasis...
  4. pmc Plasma pharmacokinetics after combined therapy of gemcitabine and oral S-1 for unresectable pancreatic cancer
    Bunzo Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka 545 8585, Japan
    J Exp Clin Cancer Res 29:15. 2010
    ..The combination of gemcitabine (GEM) and S-1, an oral 5-fluorouracil (5-FU) derivative, has been shown to be a promising regimen for patients with unresectable pancreatic cancer...
  5. doi request reprint Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer
    Bunzo Nakata
    Department of Surgical Oncology, Institute of Geriatrics and Medical Science, Osaka City University Graduate School of Medicine, Osaka, Japan
    Oncology 74:69-75. 2008
    ..The clinical significance of chemokine receptor CCR7 expression in pancreatic ductal cancer was investigated...
  6. ncbi request reprint Comparison of clinicopathological characteristics of curatively resected pancreatic head and body/tail ductal cancers
    B Nakata
    Department of Surgical Oncology, Institute of Geriatrics and Medical Science, Osaka City University Graduate School of Medicine, Osaka, Japan
    J Exp Clin Cancer Res 26:459-66. 2007
    ..7%). Although the metastasized LN stations were different between Ph and Pbt by anatomical reason, biological malignant behaviors such as the LN metastasis rate, the overall survival, and the recurrent pattern were similar...
  7. ncbi request reprint Continuous infusion of 5-fluorouracil with versus without low-dose, consecutive administration of cisplatin in advanced colorectal cancer. A prospective randomized phase II study
    B Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
    J Exp Clin Cancer Res 26:51-60. 2007
    ....
  8. ncbi request reprint Prognostic predictive value of endoscopic ultrasound findings for invasive ductal carcinomas of pancreatic head
    Bunzo Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
    Pancreas 30:200-5. 2005
    ..We retrospectively examined the prognostic predictive values of endoscopic ultrasound (EUS) findings for patients with this disease...
  9. ncbi request reprint Moderate neutropenia with S-1 plus low-dose cisplatin may predict a more favourable prognosis in advanced gastric cancer
    B Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
    Clin Oncol (R Coll Radiol) 18:678-83. 2006
    ..The effects of haematological adverse events on the prognosis of patients with gastric cancer were investigated...
  10. ncbi request reprint Transplatin, a cisplatin trans-isomer, may enhance the anticancer effect of 5-fluorouracil
    B Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
    J Exp Clin Cancer Res 25:195-200. 2006
    ..TDDP alone, compared to CDDP alone, gave rather low cytotoxicity for these cell lines. In conclusion, TDDP might be a clinically useful modulator of 5-FU...
  11. pmc Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer
    B Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1 4 3 Asahimachi, Abeno Ku, Osaka 545 8585, Japan
    Br J Cancer 91:873-8. 2004
    ..8 vs 18.8 and 84.6 vs 46.2%, respectively). These observations suggest that serum CYFRA 21-1 may be a reliable marker of recurrence or therapeutic efficacy...
  12. doi request reprint Phase II trial of S-1 plus low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902 Step2)
    Bunzo Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Abeno Ku, Osaka, Japan
    Oncology 79:337-42. 2010
    ..The efficacy and the toxicity of oral fluorouracil derivative S-1 plus low-dose cisplatin in unresectable or recurrent gastric cancer were evaluated by a phase II study...
  13. ncbi request reprint Prognostic predictive value of 18F-fluorodeoxyglucose positron emission tomography for patients with pancreatic cancer
    B Nakata
    Department of Surgical Oncology First Department of Surgery, Osaka City University Graduate School of Medicine, Osaka 545 8585, Japan
    Int J Oncol 19:53-8. 2001
    ..Moreover, a multivariate analysis of survival indicated that SUV is an independent prognostic factor for patients with unresectable pancreatic cancer...
  14. ncbi request reprint Prognostic value of microsatellite instability in resectable pancreatic cancer
    Bunzo Nakata
    Department of Surgical Oncology, Osaka City University Medical School, Osaka 545 8585, Japan
    Clin Cancer Res 8:2536-40. 2002
    ..In conclusion, a patient with MSI-positive pancreatic cancer may have a comparatively better prognosis after resection, possibly due to intensive immunoreaction to the tumor...
  15. ncbi request reprint Genetic alterations in adenoma-carcinoma sequencing of intraductal papillary-mucinous neoplasm of the pancreas
    Bunzo Nakata
    Department of Surgical Oncology First Department of Surgery, Osaka City University Graduate Shool of Medicine, 1 4 3 Asahimachi, Abeno Ku, Osaka 545 8585, Japan
    Int J Oncol 21:1067-72. 2002
    ..Taken together, genetic changes such as K-ras, p53, APC and DCC mutations may not be associated with adenoma-carcinoma sequence in intraductal papillary-mucinous neoplasm of pancreas...
  16. ncbi request reprint Very low incidence of microsatellite instability in intraductal papillary-mucinous neoplasm of the pancreas
    Bunzo Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
    Int J Cancer 102:655-9. 2002
    ..All IPMCs and IPMAs showed normal expression of both hMLH1 and hMSH2. MSI-H and loss of hMLH1 and hMSH2 are very rare events in both IPMCs and IPMAs. We conclude that a good prognosis for patients with IPMC is not associated with MSI-H...
  17. ncbi request reprint Negative hMSH2 protein expression in pancreatic carcinoma may predict a better prognosis of patients
    Bunzo Nakata
    Department of Surgical Oncology First Department of Surgery, Osaka City University Graduate School of Medicine, 1 4 3 Asahimachi, Abeno Ku, Osaka 545 8585, Japan
    Oncol Rep 10:997-1000. 2003
    ..The patients with hMSH2-negative tumors may have better prognoses than those with hMSH2-positive tumors. To clarify these findings, further large number of pancreatic carcinomas must be investigated...
  18. ncbi request reprint Differences in dihydropyrimidine dehydrogenase activities between gastric and colorectal cancer
    Bunzo Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1 5 4 Asahimachi, Abeno Ku, Osaka 545 8585, Japan
    Dig Dis Sci 49:60-4. 2004
    ....
  19. ncbi request reprint Combination phase I trial of a novel oral fluorouracil derivative S-1 with low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902)
    Bunzo Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
    Clin Cancer Res 10:1664-9. 2004
    ..The Japanese Foundation for Multidisciplinary Treatment of Cancer conducted a Phase I study of a novel oral fluorouracil derivative, S-1, combined with a low dose of cisplatin in unresectable and recurrent gastric cancer...
  20. doi request reprint Predictive value of expression of ERCC 1 and GST-p for 5-fluorouracil/oxaliplatin chemotherapy in advanced colorectal cancer
    Eiji Noda
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
    Hepatogastroenterology 59:130-3. 2012
    ....
  21. doi request reprint In vitro and in vivo evidence that a combination of lapatinib plus S-1 is a promising treatment for pancreatic cancer
    Masahiro Komoto
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
    Cancer Sci 101:468-73. 2010
    ..Both lapatinib monotherapy and combined treatment with S-1 may be promising treatments for patients with pancreatic cancers; the majority these cancers express lapatinib target molecules...
  22. ncbi request reprint Dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 may be effective against peritoneal dissemination in gastric cancer
    Shigehito Yamagata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1 4 3 Asahimachi, Abeno Ku, Osaka 545 8585, Japan
    Oncol Rep 12:973-8. 2004
    ..High concentrations of CDHP may prevent 5-FU degradation in peritoneal dissemination and its surrounding fibrous tissue...
  23. ncbi request reprint [Results of neo-adjuvant chemotherapy by FOLFOX and FOLFIRI for colorectal liver metastasis]
    Ryosuke Amano
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine
    Gan To Kagaku Ryoho 36:2003-5. 2009
    ..Now, 9 patients are alive with no recurrence. NAC by FOLFOX for liver metastasis of colorectal cancer showed a high reduction rate, and there was a little influence to hepatectomy indicating that FOLFOX could be an effective therapy...
  24. ncbi request reprint [Combination therapy of a novel oral fluorouracil derivative TS-1 with low-dose cisplatin for recurrent and very advanced gastric cancer]
    Bunzo Nakata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1 4 3 Asahimachi, Abeno Ku, Osaka 545 8585, Japan
    Gan To Kagaku Ryoho 31:1962-8. 2004
    ..In conclusion, TS-1 + low-dose CDDP combination therapy will be done on an outpatient basis in future, and may be examined as a neoadjuvant therapy as well as a conventional form of chemotherapy...
  25. doi request reprint HER3 overexpression as an independent indicator of poor prognosis for patients with curatively resected pancreatic cancer
    Toshiki Hirakawa
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Abeno Ku, Osaka, Japan
    Oncology 81:192-8. 2011
    ..The association between human epidermal growth factor receptor 3 (HER3) overexpression and survival in patients with curatively resected pancreatic cancer was investigated...
  26. ncbi request reprint [S-1+Low-Dose CDDP]
    Bunzo Nakata
    Dept of Surgical Oncology, Osaka City University Graduate School of Medicine, Japan
    Gan To Kagaku Ryoho 33:68-74. 2006
    ..There have been no differences between the case reports and the clinical studies in quantity and quality for both regimens. The unified regimen of S-1+low-dose CDDP as an outpatient based chemotherapy should be developed...
  27. ncbi request reprint Efficacy of S-1 for gastric cancer patients with positive peritoneal lavage cytology
    Eiji Ako
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1 4 3 Asahi machi, Abeno Ku, Osaka, 545 8585, Japan
    Hepatogastroenterology 55:1939-42. 2008
    ..We examined the clinical efficacy of S-1 chemotherapy against gastric cancer with positive PLC after macroscopically curative resection...
  28. ncbi request reprint Intraductal papillary-mucinous adenoma developed in the ventral pancreas in a patient with pancreas divisum
    Yoji Sakate
    First Department of Surgery, Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1 4 3 Asahi machi, Abeno Ku, 545 8585, Osaka, Japan
    J Hepatobiliary Pancreat Surg 11:366-70. 2004
    ..Although in these three patients the tumor developed in the dorsal pancreas, the tumor developed in the ventral pancreas in our patient...
  29. doi request reprint HER2 overexpression correlates with survival after curative resection of pancreatic cancer
    Masahiro Komoto
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
    Cancer Sci 100:1243-7. 2009
    ..These results should encourage further investigation of treatments using new molecular targeting agents against HER2 protein to improve the survival of pancreatic cancer patients...
  30. ncbi request reprint Immunohistochemical assessment for estrogen receptor and progesterone receptor status in breast cancer: analysis for a cut-off point as the predictor for endocrine therapy
    Yoshinari Ogawa
    Department of Surgery, Osaka City General Hospital, 2 13 22 Miyakojima Hondori, Miyakojima ku, Osaka, 534 0021, Japan
    Breast Cancer 11:267-75. 2004
    ..However, the proper cut-off points of IHC have not been established. Cut-off points for ER and PR status as predictive factors for endocrine therapy are needed...
  31. ncbi request reprint Vitamin D receptor expression is associated with colon cancer in ulcerative colitis
    Koji Wada
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
    Oncol Rep 22:1021-5. 2009
    ..These findings suggested that correlation seems to exist between the level of VDR expression and carcinogenesis in UC. VDR could be a possible marker to detect dysplasia and cancer in ulcerative colitis...
  32. ncbi request reprint A case of osteoclast-type giant cell tumor of the pancreas with high-frequency microsatellite instability
    Hirohisa Osaka
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
    Pancreas 29:239-41. 2004
    ..It has been reported that pancreatic carcinomas with MSI-H status have a favorable outcome. MSI-H might be one of the predictive markers for the long survival in OGTP...
  33. ncbi request reprint Oral UFT and cyclophosphamide combination chemotherapy for metastatic breast cancer
    Yoshinari Ogawa
    Department of Surgery, Osaka City General Hospital, Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
    Anticancer Res 23:3453-7. 2003
    ..Effective long-term chemotherapy yielding good quality of life is essential. The clinical benefits of oral UFT and cyclophosphamide (CPA) combination chemotherapy for metastatic breast cancer (MBC) were evaluated...
  34. ncbi request reprint Gastric cancer with cervical lymph node metastasis as the first presentation: report of a case
    Tsutomu Takashima
    Department of Surgery, Osaka Socio Medical Center, Osaka City University Graduate School of Medicine, Abeno Ku, Osaka, Japan
    Int Surg 93:295-9. 2008
    ..Rapid progression of hoarseness was observed, and weekly docetaxcel was started. However, he died of airway obstruction 8 months after surgery...
  35. pmc IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer
    Toshiki Hirakawa
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1 4 3 Asahi machi, Osaka, Abeno Ku, Japan
    BMC Cancer 13:392. 2013
    ..In this study, IGF1R and IGFBP3 expression was examined, and their potential roles as prognostic markers in patients with pancreatic cancer were evaluated...
  36. ncbi request reprint Alternative pharmacokinetics of S-1 components, 5-fluorouracil, dihydrofluorouracil and alpha-fluoro-beta-alanine after oral administration of S-1 following total gastrectomy
    Woo Young Kim
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka 545 8585, Japan
    Cancer Sci 98:1604-8. 2007
    ..However, the dose of S-1 for patients who have undergone total gastrectomy might be diminished to avoid severe adverse events and to continue the treatment for a long period...
  37. pmc Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer
    Reiko Ashida
    Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan
    J Exp Clin Cancer Res 28:83. 2009
    ..The aim of this study was to determine a predictive indicator of gemcitabine (GEM) efficacy in unresectable pancreatic cancer using tissue obtained by endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA)...
  38. pmc Prognostic predictive values of gemcitabine sensitivity-related gene products for unresectable or recurrent biliary tract cancer treated with gemcitabine alone
    Akihiro Murata
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Abeno Ku, Osaka, Japan
    World J Surg Oncol 11:117. 2013
    ..The aim of this study is to clarify which biomarker is the most reliable among hENT1, dCK, and RRM1 to predict survival in patients with advanced BTC treated with gemcitabine alone...
  39. ncbi request reprint [Risk factor for pancreatic cancer--alcoholic abuse]
    Hiroji Nishino
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine
    Nihon Rinsho 64:14-7. 2006
  40. ncbi request reprint Caspase-8 is scarcely silenced and its activity is well correlated with the anticancer effect of tumor necrosis factor-related apoptosis-inducing ligand in gastric cancer cells
    Isao Kanehara
    Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1 4 3 Asahimachi, Abeno Ku, Osaka 545 8585, Japan
    Oncol Rep 14:1249-53. 2005
    ..The anticancer efficacy may be predicted by the degree of caspase-8 activation after TRAIL treatment...
  41. ncbi request reprint [A case of anthracycline and taxane-resistant breast cancer with life-thereatening multiple liver metastases responding to oral combination chemotherapy by UFT, cyclophosphamide and medroxyprogesterone acetate]
    Tetsuro Ishikawa
    Dept of Surgical Oncology, Osaka City University Graduate School of Medicine
    Gan To Kagaku Ryoho 32:687-90. 2005
    ..Lung metastasis also subsided. In spite of these good responses, tumor markers did not normalize and skin nodules appeared around the surgical site. Administration was stopped 36 weeks after initiation of the treatment...
  42. ncbi request reprint Phase I/II study of combination therapy of oral fluorinated pyrimidine compound S-1 with low-dose cisplatin in patients with unresectable and/or recurrent advanced gastric cancer: a novel study design to evaluate safety and efficacy
    Satoshi Morita
    Department of Epidemiological and Clinical Research Information Management, Kyoto University Graduate School of Medicine, Yoshida konoe cho, Sakyo ku, Kyoto 606 8501, Japan
    Jpn J Clin Oncol 34:159-61. 2004
    ..The goal of this trial is to establish a useful chemotherapeutic treatment in an outpatient setting...
  43. ncbi request reprint [A case of gastric cancer with umbilical metastasis that responded to TS-1 with low-dose cis-platinum]
    Tsutomu Takashima
    Dept of Surgical Oncology, Osaka City University Graduate School of Medicine
    Gan To Kagaku Ryoho 31:247-50. 2004
    ..The gastric lesion and umbilical nodule showed marked response to the chemotherapy and the response continued for 20 months. The patient died of disease progression 31 months after the initiation of the treatment...
  44. ncbi request reprint [Changes in tumor marker levels as a predictor of gemcitabine effect on patients with unresectable or recurrent pancreatic cancer]
    Masashige Tendo
    Dept of Surgical Oncology, Osaka City University Graduate School of Medicine
    Gan To Kagaku Ryoho 32:795-8. 2005
    ..3%) leukopenia, 2 (8.7%) thrombocytopenia, and 1 (4.3%) skin toxicity. In conclusion, the tumor marker change after GEM treatment may be a predictor of preferable prognosis in patients with pancreatic cancer...
  45. doi request reprint A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method
    Satoshi Morita
    Program in Health and Community Medicine, Nagoya University Graduate School of Medicine, 65 Tsuruma cho, Showa Ku, Nagoya 466 8550, Japan
    Jpn J Clin Oncol 37:924-9. 2007
    ....
  46. ncbi request reprint [A case of gastric cancer with peritoneal recurrence which developed during adjuvant administration of TS-1 showing complete response by weekly docetaxel regimen]
    Tsutomu Takashima
    Dept of Surgery, Osaka Socio Medical Center, Osaka City University, Graduate School of Medicine
    Gan To Kagaku Ryoho 32:1041-4. 2005
    ..The patient has survived without disease one year after cessation of the treatment. Weekly docetaxel is a safe and effective regimen for gastric cancer worth using for a second-line therapy after failure of the 5-FU-based regimen...